fda glp-1 warning september 2025 letters compounded Fda Warning Letters Glp- 1 Compounded September 2025 There's lots going on this month at FDA What Patients Need to Know

When to Contact Your Doctor About GLP-1 Heartburn Mild heartburn that improves within 24 weeks of starting tirzepatide or a dose increase is expected and does not require medication changes

Talk to your healthcare provider if youre taking a GLP-1 or dual GIP/GLP-1 receptor agonist (Mounjaro/Zepbound) and are interested in taking berberine

The main ongoing monitoring concerns are gastrointestinal tolerability, potential thyroid tumor risk (based on animal studies

J Nutr 150(7):18451851 Farsijani S, Morais JA, Payette H, Gaudreau P, Shatenstein B, Gray-Donald K et al (2016) Relation between mealtime distribution of protein intake and lean mass loss in free-living older adults of the NuAge study

Rock concerts have seen less excitement

A counseling session should be performed to make sure that the patient is well informed about the potential adverse events associated with these medications